Professional Documents
Culture Documents
Drug Study Mugna
Drug Study Mugna
Drug Study Mugna
Intra-articular
injection: Joint
damage, fibrosis
Generic Decreases fever Relief of mild-to- -Hypersensitivity Stimulation, drowsiness, Thrombocytopenia Assess patient’s fever or
Name: by inhibiting the moderate pain; nausea, vomiting, , anaphylaxis, pain: type of pain,
Paracetamol effects of treatment of fever. -intolerance to abdominal pain, cutaneous location, intensity,
pyrogens on the tartrazine (yellow dye hepatotoxicity, hepatic hypersensitivity duration, temperature,
hypothalamus #5), alcohol, table seizure (overdose, Renal reactions including and diaphoresis.
heat regulating sugar, saccharin failure (high, prolonged skin rashes,
Brand Name: Assess allergic reactions:
centers & by a doses), leucopenia, angioedema &
hypothalamic -Contraindicated with neutropenia, hemolytic Stevens-Johnson rash, urticaria; if these
action leading to allergy to anemia (long term use) syndrome, occur, drug may have to
sweating & acetaminophen thrombocytopenia, bronchospasm in be discontinued.
vasodilatation. pancytopenia, rash, patients sensitive
urticaria, to aspirin & other Teach patient to recognize
Classification: Relieves pain by hypersensitivity, NSAIDs, hepatic signs of chronic overdose:
Analgesic inhibiting cyanosis, anemia, dysfunction. bleeding, bruising,
Muscle prostaglandin jaundice, CNS, malaise, fever, sore
relaxants synthesis at the stimulation, delirium throat.
CNS but does not followed by vascular
MECHANISM OF INDICATIONS CONTRAINDICATION ADVERSE NURSING
DRUG SIDE EFFECTS
ACTION OR PURPOSE S REACTIONS RESPONSIBILITIES
Date, Route,
Timing:
1.2 ml PO
Q4H PRN or
PCM 100 mg
IVTT Q4H for
Temp > 38ºC
have anti- collapse, convulsions, Tell patient to notify
inflammatory coma, death. prescriber for pain/ fever
action because of lasting for more than 3
its minimal effect days.
on peripheral
prostaglandin
synthesis.